Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Lexicon Pharmaceuticals, Inc. logo

Lexicon Pharmaceuticals, Inc. (LXRX) Stock Ticker

NASDAQ: LXRX · Healthcare · Biotechnology
$1.79-3.49%
USD · as of 2026-09-28 · market cap $797.3M
Open LXRX in TickrDownload for iPhone

LXRX right now

Options price it to move more than 9 in 10 stocks.
Options expect by Oct 6±11.7%
Options expect by Oct 29±24.3%
Priced in for Nov 5 earnings±27.0%
IV rank (30-day)12% · cheap
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full LXRX picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on LXRX
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the end-to-end process of identifying, advancing, and bringing to market novel therapeutic compounds. Its development pipeline includes orally administered small molecule drug candidates such as Sotagliflozin, which has successfully concluded Phase III clinical studies for treating both heart failure and type 1 diabetes, and LX9211, currently undergoing Phase II clinical development for neuropathic pain. The firm maintains important strategic collaborations and licensing arrangements with pharmaceutical industry leaders, including Bristol-Myers Squibb Company and Genentech, Inc. Established in 1995, Lexicon Pharmaceuticals, Inc. is based in The Woodlands, Texas.

LXRX stock facts

Ticker symbolLXRX
ExchangeNASDAQ Global Select
SectorHealthcare
IndustryBiotechnology
Market cap$797.3M
CEOMichael S. Exton
Employees81
HeadquartersThe Woodlands, TX, US
IPO date2000-04-07
Websitewww.lexpharma.com

What you can see for LXRX on Tickr

Live LXRX price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the LXRX report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Lexicon Pharmaceuticals, Inc.?

The ticker symbol for Lexicon Pharmaceuticals, Inc. is LXRX, listed on the NASDAQ Global Select.

What is LXRX?

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the end-to-end process of identifying, advancing, and bringing to market novel therapeutic compounds. Its development pipeline includes orally administered small molecule drug candidates such as Sotagliflozin, which has successfully concluded Phase III clinical studies for treating both heart failure and type 1 diabetes,…

HomeExploreMarketLists
All pages